IRAK4 and myelodysplastic syndrome: The oncogenic long form of IRAK-4 (IRAK4-L) has been found to be overexpressed in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) and portends a worse prognosis (6, 65).